"Mercy Health - St. Anne Cancer Center in Toledo, Ohio is one of Mercy Health's many Cancer Care and Oncology locations serving communities across Ohio and Kentucky."

During the past decade, Mercy Cancer Center at Saint Anne Mercy Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center at Saint Anne Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Morphotek" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Oncolytics Biotech" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center at Saint Anne Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center at Saint Anne Mercy Hospital" are "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Prostate" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Squamous Cell of the Head and Neck" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Mercy Cancer Center at Saint Anne Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center at Saint Anne Mercy Hospital" are "Drug" (7 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Placebo" (2 trials), "Best supportive care" (1 trials), "Carboplatin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center at Saint Anne Mercy Hospital" are 5 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Cancer Center at Saint Anne Mercy Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mercy Cancer Center at Saint Anne Mercy Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center at Saint Anne Mercy Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".